Add BrightSurf on Google Email

Science News for December 14, 1999


Scientists report marker of increased cancer risk in women with benign breast disease

Researchers found a link between reduced TGFb receptor expression and increased breast cancer risk in women with benign breast disease. The study identified 54 women who developed invasive breast cancer after initial hyperplasia diagnosis, highlighting the importance of molecular markers in predicting breast cancer risk.

SourceVanderbilt University Medical Center·JournalJNCI Journal of the National Cancer Institute·DateDec 14, 1999

Penn study shows that most battered women know their attackers and many assaults occur in public

A new Penn study found that over 50% of violently assaulted women were attacked by non-intimates, and most knew or were acquainted with their attackers. The majority of these victims were beaten in public, highlighting the need for crisis interventions within Emergency Departments and long-term community programs.

SourceUniversity of Pennsylvania School of Medicine·JournalNew England Journal of Medicine·DateDec 14, 1999

Novel molecule blocks pain receptor system

Researchers at Banyu Pharmaceutical Co. in Japan have designed a synthetic molecule that can block the molecular pathway of the opioid receptor-like 1 (ORL-1), leading to a better understanding of pain regulation. This breakthrough finding may pave the way for new and improved drugs to treat pain, as well as other neurological disorders.

SourceAmerican Chemical Society·JournalJournal of Medicinal Chemistry·DateDec 14, 1999

Can exercise prevent fainting?

Researchers aim to develop an exercise regimen that can prevent fainting in healthy individuals. Dr. William H. Cooke's study found that a malfunction in arterial pressure sensors and inadequate neural response to blood volume decreases may cause fainting. The investigation explores the effects of different exercise training programs o...

Better care for severely depressed costs less

A new stepped-care intervention program called Collaborative Care has shown significant improvement in treating severely depressed patients, with a recovery rate of 40% compared to 23% for those receiving usual primary care. The program reduced costs per case successfully treated, offering good news for patients and healthcare systems.

SourceCenter for Advancing Health·JournalArchives of General Psychiatry·DateDec 14, 1999